Your baseline target is 64 to 80 ounces daily
We wanted to see if losing 20% or more of body weight would have a major effect on mortality, cardiovascular morbidity and other forms of morbidity
What Really Happens When a GLP-1 Medication Stops People who discontinue GLP-1 medications such as semaglutide (Wegovy) and tirzepatide (Zepbound) commonly experience meaningful weight regain, with most recovering much of their lost weight over the following couple of years, as Harvard Healths overview on transitioning off GLP-1 medications summarizes
1 Department of Internal Medicine, Maastricht University, Maastricht, Netherlands, 2 Division of Epidemiology and Community Health, School of Public Health, University of Minnesota Medical School, Minneapolis, MN, USA, 3 Ocular Epidemiology, University of Wisconsin-Madison, Madison, WI, USA, 4 Department of Social Medicine, Maastricht University, Maastricht, Netherlands, 5 Division of Epidemiology and Clinical Applications, National Eye Institute, Bethesda, MD, USA, 6 Department of Biostatistics, University of Washington, Seattle, WA, USA, 7 Department of Social Sciences and Health Policy, Wake Forest School of Medicine, Winston Salem, NC, USA, 8 Department of Internal Medicine, Wake Forest School of Medicine, Winston Salem, NC, USA, 9 Department of Epidemiology & Prevention, Wake Forest School of Medicine, Winston Salem, NC, USA, 10 Department of Vascular Medicine, University Medical Center Utrecht, Utrecht, Netherlands
Proc Natl Acad Sci Usa 2022;119:e2206053119
Which of the following is not a possible side effect of GLP-1 receptor agonists
